[Drug treatment efficacy in 32 children with streptococcal toxic shock syndrome]

Area of Science:

• Pediatric Infectious Diseases
• Microbiology
• Pharmacology

Context:

• Streptococcal toxic shock syndrome (STSS) is a severe, life-threatening condition in children.
• Optimal antimicrobial therapy for STSS remains a critical clinical challenge.
• Limited data exists on comparative efficacy of various drug regimens in pediatric STSS cases.

Purpose:

• To evaluate the effectiveness of different antimicrobial drug treatment regimens for pediatric STSS.
• To compare the clinical outcomes of four distinct treatment strategies for STSS in children.
• To identify the most efficacious antimicrobial approach for improving therapeutic outcomes in pediatric STSS.

Summary:

• A retrospective analysis of 32 pediatric STSS cases revealed significant differences in treatment efficacy across four drug regimens.
• Antimicrobial susceptibility testing indicated universal sensitivity to beta-lactam antibiotics like penicillin and vancomycin.
• The standard regimen, including penicillin, achieved 100% efficacy, while carbapenem-based, other broad-spectrum, and macrolide/no-drug groups showed 40%, 40%, and 0% efficacy, respectively.

Impact:

• Findings suggest that antimicrobial regimens incorporating penicillin significantly enhance therapeutic efficacy in pediatric STSS.
• This study provides evidence-based recommendations for optimizing antibiotic selection in managing pediatric STSS.
• Results highlight the importance of antimicrobial stewardship and susceptibility-guided therapy for severe pediatric infections.